Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.6 - $1.53 $133,154 - $339,543
-221,924 Reduced 75.0%
73,957 $44,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $91,897 - $142,659
87,521 Added 42.0%
295,881 $334,000
Q1 2023

May 15, 2023

BUY
$1.2 - $2.73 $175,149 - $398,465
145,958 Added 233.9%
208,360 $281,000
Q4 2022

Feb 14, 2023

SELL
$1.71 - $3.61 $226,340 - $477,830
-132,363 Reduced 67.96%
62,402 $116,000
Q3 2022

Nov 14, 2022

BUY
$1.9 - $8.63 $23,411 - $106,338
12,322 Added 6.75%
194,765 $479,000
Q2 2022

Aug 15, 2022

SELL
$2.13 - $9.01 $1.34 Million - $5.68 Million
-630,101 Reduced 77.55%
182,443 $445,000
Q1 2022

May 16, 2022

BUY
$6.28 - $15.59 $2.86 Million - $7.11 Million
456,066 Added 127.94%
812,544 $6.48 Million
Q4 2021

Feb 14, 2022

BUY
$14.7 - $28.67 $2.39 Million - $4.66 Million
162,627 Added 83.89%
356,478 $5.44 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $1.63 Million - $2.26 Million
67,163 Added 53.01%
193,851 $5.51 Million
Q2 2021

Aug 16, 2021

BUY
$26.09 - $40.4 $2.76 Million - $4.28 Million
105,941 Added 510.63%
126,688 $4.27 Million
Q1 2021

May 17, 2021

SELL
$33.06 - $56.93 $538,150 - $926,706
-16,278 Reduced 43.96%
20,747 $793,000
Q4 2020

Feb 16, 2021

SELL
$39.09 - $57.4 $2.4 Million - $3.53 Million
-61,513 Reduced 62.43%
37,025 $1.55 Million
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $2.86 Million - $4.49 Million
-100,595 Reduced 50.52%
98,538 $4.27 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $2.17 Million - $5.61 Million
185,372 Added 1347.08%
199,133 $6.03 Million
Q1 2020

May 15, 2020

SELL
$7.64 - $27.5 $1.9 Million - $6.86 Million
-249,298 Reduced 94.77%
13,761 $188,000
Q4 2019

Feb 14, 2020

BUY
$15.02 - $20.57 $3.68 Million - $5.04 Million
245,159 Added 1369.6%
263,059 $4.24 Million
Q3 2019

Nov 14, 2019

BUY
$18.85 - $27.5 $337,415 - $492,250
17,900 New
17,900 $345,000
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $3.07 Million - $4.65 Million
-176,952 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$10.65 - $25.75 $1.6 Million - $3.88 Million
150,503 Added 569.03%
176,952 $4.14 Million
Q4 2018

Feb 14, 2019

BUY
$9.26 - $16.38 $144,881 - $256,281
15,646 Added 144.83%
26,449 $293,000
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $81,454 - $197,802
10,803 New
10,803 $181,000
Q4 2017

Feb 14, 2018

SELL
$7.86 - $9.99 $108,719 - $138,181
-13,832 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$8.89 - $10.4 $122,966 - $143,852
13,832
13,832 $130,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.